跳至主要内容
临床试验/NCT05376046
NCT05376046招募中不适用

Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease

BILLOIR1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Hospitalisation for Vaso-occlusive crisis within one years

研究概览

简要总结

Sickle cell disease (SCD) is an inherited haemoglobinopathy disorder caused by mutations in HBB gene with amino-acid substitution on β globin chain. The consequence is synthesis of altered haemoglobin S (HbS) which polymerises in red blood cell (RBC) at deoxygenated state. SCD is associated with chronic haemolytic anaemia, vaso-occlusive crisis (VOC) leading to frequent hospitalisation.

The aim of the study was to to investigate whether a combination of routine laboratory biomarkers of haemolysis could be used to predict VOC development in confirmed SCD patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sickle cell disease

排除标准

  • <18 years
  • pregnancy
  • Patient under protective guardianship or curatorship

结局指标

主要结局

Hospitalisation for Vaso-occlusive crisis within one years

时间窗: 1 year

Following injury consultation, evaluation of biological markers predicting vaso-occlusive crisis requiring hospitalisation in the year

次要结局

未报告次要终点

研究者

发起方
BILLOIR
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

BILLOIR

Associate Professor

University Hospital, Rouen

研究点 (1)

Loading locations...

相似试验